Peking Union Medical College, founded in 1906, is one of the most selective medical colleges in China
The Latest Bing News on:
Peking Union Medical College Research
- Children of the Yellow Earth: Studies in Prehistoric China
1934), Professor at the Peking Union Medical College, who with such penetrating genius identified and described Sinanthropus pekinensis.” Not only did Dr. Andersson discover the site of the ...
- A Novel Combined-catheter to Monitor Left and Right Atrial Pressures
We thank the nursing staff from the PICU for assisting with this research ... Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 2 Department of Surgery and ...
- Senior Chinese lawmaker stresses making rare disease treatment more law-based
He also visited the Center for Drug Evaluation of the National Medical Products Administration, as well as the Peking Union Medical College Hospital. Enditem ...
- First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China
Bing Han MD, PhD, Chief Physician and Professor in the Department of Hematology at Peking Union Medical College Hospital ... company committed to the research, development and commercialization ...
- First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China
CANbridge Pharmaceuticals Inc. (HKEX:1228), a China and US-based global biopharmaceutical company committed to the research, development and commercialization of transformative rare disease and rare ...
The Latest Google Headlines on:
Peking Union Medical College Research
The Latest Bing News on:
Peking Union Medical College Discovery
- GenFleet Receives CTAs Approval for Two Phase II Combination Studies of TGF-β R1 Inhibitor (GFH018) with PD-1 Inhibitor
GFH018 is a small molecule drug designed to specifically target and inhibit TGF-β R1, and the discovery and ... of Sichuan University, Peking Union Medical College Hospital.
- GenFleet Receives CTAs Approval for Two Phase II Combination Studies of TGF-β R1 Inhibitor (GFH018) with PD-1 Inhibitor
GFH018 is a small molecule drug designed to specifically target and inhibit TGF-β R1, and the discovery and development of ... West China Hospital of Sichuan University, Peking Union Medical College ...
- GenFleet Receives CTAs Approval for Two Phase II Combination Studies of TGF-β R1 Inhibitor (GFH018) with PD-1 Inhibitor
Get 7 Days Free Sign In Sign In Topics ...
- First Patient Dosed in CANbridge Pharmaceuticals CAN103 Phase 1/2 Trial for the Treatment of Gaucher Disease in China
Bing Han MD, PhD, Chief Physician and Professor in the Department of Hematology at Peking Union Medical College Hospital in Beijing, China, is the principal investigator for this multi-site trial, ...
- SCG Cell Therapy Presents Clinical Proof-of-Concept Data at International Liver Congress (ILC) 2022 Annual Meeting
Peking Union Medical College and principal investigator for the trial. "Chronic HBV infection accounts for more than half of all patients with liver cancer worldwide. The development of HBV ...
